June 17, 2015 — This brief animation shows how a new drug screening technology developed at the Harvard T.H. Chan School of Public Health has identified a new potential anti-diabetes compound — and a powerful way to test whether other molecules can have a positive effect on a critical molecular pathway in the endoplasmic reticulum that is believed to be the underlying cause of type 2 diabetes. (1:10)